Company Filing History:
Years Active: 2003-2017
Title: Franz Kricek: Innovations in Pain Management
Introduction
Franz Kricek, an innovative inventor based in Biedermannsdorf, Austria, has made significant contributions to the field of pharmaceutical sciences. With a total of four patents to his name, his work primarily focuses on compounds that aid in the treatment of pain and various disorders affecting the central nervous system.
Latest Patents
One of Franz Kricek's latest patents involves the development of γ-aminobutyric acid (GABA) analogues specifically designed for the treatment of neuropathic pain. His patent describes a compound of Formula 1 or its tautomers, showcasing processes to prepare these compounds along with novel intermediates. The compounds are characterized by various substituents, including hydrogen, halo, and various alkyl groups, which enhance their utility in treating neuropathic pain and disorders of the central nervous system. Furthermore, these compounds can exist as pharmaceutically acceptable salts or solvates, further broadening their potential applications.
Career Highlights
Throughout his career, Franz Kricek has worked with prominent companies in the pharmaceutical industry, such as Novartis AG and Novassay S.A. His expertise and innovative perspective have greatly contributed to the advancement of treatments for pain management.
Collaborations
Franz has collaborated with esteemed colleagues including Beda Stadler and Premji Meghani. These partnerships have played a crucial role in the development of his patents and the pursuit of novel solutions in the realm of pain treatment.
Conclusion
Franz Kricek exemplifies the spirit of innovation within the pharmaceutical field through his dedication to research and development. His latest patents pave the way for enhanced treatments for patients suffering from pain and neurological disorders, marking significant progress in the scientific community.